文献速递产科麻醉

帕洛诺司琼与昂丹司琼预防腰麻剖宫产鞘内吗啡所致恶心呕吐及瘙痒的随机对照试验

A Randomized, Controlled Trial of Palonosetron Versus Ondansetron for Nausea, Vomiting, and Pruritus in Cesarean Delivery with Intrathecal Morphine.
PubMed 文献 · Anesth Analg · 2024-10-30

该随机对照试验纳入300例腰麻剖宫产产妇,比较帕洛诺司琼0.075mg、昂丹司琼4mg与生理盐水对鞘内吗啡所致术后恶心呕吐(PONV)和瘙痒的预防效果。帕洛诺司琼组48小时PONV和瘙痒发生率均显著低于生理盐水组,但与昂丹司琼组无显著差异。

要点

  • 帕洛诺司琼可有效降低剖宫产鞘内吗啡所致PONV和瘙痒发生率。
  • 帕洛诺司琼与昂丹司琼在预防PONV和瘙痒方面疗效无显著差异。
  • 帕洛诺司琼组瘙痒需纳布啡补救的例数显著少于生理盐水组。

核心结论

  • 帕洛诺司琼能有效预防剖宫产鞘内吗啡所致的PONV和瘙痒,但效果与昂丹司琼无显著差异。

研究设计与样本

  • 随机对照试验,纳入300例腰麻剖宫产产妇,随机分为帕洛诺司琼0.075mg组、昂丹司琼4mg组和生理盐水组,最终297例完成研究。

主要发现

  • 三组间PONV补救、满意度评分及不良事件无显著差异。

临床怎么用

  • 剖宫产腰麻鞘内吗啡镇痛时,可考虑使用帕洛诺司琼预防PONV和瘙痒,但其疗效不优于昂丹司琼。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Spinal anesthesia is the preferred anesthetic technique for cesarean deliveries. Postoperative nausea and vomiting (PONV) and pruritus occur in up to 80% and 83% of patients, respectively, after cesarean delivery with intrathecal opioids. Ondansetron is the recommended medication for PONV prophylaxis, but palonosetron, a second-generation 5-HT3 receptor antagonist, has a higher receptor affinity and a longer half-life. However, studies on palonosetron use in cesarean deliveries are limited. This study aimed to determine whether palonosetron was more effective than ondansetron in preventing intrathecal morphine-induced PONV and pruritus in cesarean deliveries. METHODS: Parturients who underwent cesarean delivery under spinal anesthesia were randomized into 3 groups: P (palonosetron 0.075 mg), O (ondansetron 4 mg), and N (normal saline). The study drug was intravenously administered after the umbilical cord was clamped. The primary outcome measures were the 48-hour incidence of PONV and pruritus. The secondary outcome measures were the PONV and pruritus scores at the postanesthesia care unit (PACU) and ward, rescue medications, satisfaction scores, and adverse events. Ordinal data were analyzed using the Kruskal-Wallis test. Continuous and categorical data were analyzed using a 1-way analysis of variance, Kruskal-Wallis test, and Pearson's χ 2 test, respectively. A value of P < .05 was considered significant. Post hoc analysis pairwise comparisons with Bonferroni correction were also performed. RESULTS: Overall, 300 parturients were enrolled, and 297 parturients completed the study. One patient in the P group and 2 in the O group were excluded because of conversion to general anesthesia after failed spinal anesthesia. The baseline patient characteristics were comparable between the groups. The PONV incidence rates in the P, O, and N groups were 26.3% (95% confidence interval [CI], 17.4-35.1), 34.7% (95% CI, 25.1-44.3), and 50.0% (95% CI, 40.0-59.9), respectively ( P = .002). The incidence rates of pruritus in the P, O, and N groups were 69.7% (95% CI, 60.5-78.9), 76.5% (95% CI, 67.9-85.1), and 87.0% (95% CI, 80.3-93.7), respectively ( P = .013). Pairwise comparisons revealed significantly lower incidences of PONV and pruritus in the P group than in the N group ( P < .001 and P = .003, respectively). However, no significant differences were observed between the P and O groups or between the O and N groups. Additionally, the P group required significantly less nalbuphine rescue for pruritus than the N group ( P = .004 and P = .005 for the PACU and ward, respectively). PONV rescue, satisfaction scores, and adverse events were not significantly different among the 3 groups. CONCLUSIONS: Palonosetron effectively prevents intrathecal morphine-induced PONV and pruritus during cesarean delivery. However, the efficacy of palonosetron is not significantly different from that of ondansetron.

来源:Anesth Analg,查看原文。版权归原作者所有。

引用

  1. Worravitudomsuk T, Charuluxananan S, Sukumpanumet W, et al. A Randomized, Controlled Trial of Palonosetron Versus Ondansetron for Nausea, Vomiting, and Pruritus in Cesarean Delivery with Intrathecal Morphine. Anesth Analg. 2024. PMID: 39475831. doi:10.1213/ANE.0000000000007091

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。